ResultsIQ

ResultsIQ › Latest results › Aptus Pharma Ltd

Aptus Pharma Ltd (APPL) quarterly results

NSE: APPL · BSE: 544529

AI summary: Results deck, Q1 FY27

Results deck of 21 Aug 2026, summarised by AI from the filing.

FY26 revenue from operations ₹46.57 cr, up 89.7%, with PAT ₹4.62 cr, up 49.0%.

Key takeaways

  1. FY26 revenue Revenue from operations ₹46.57 cr (FY25: ₹24.56 cr, +89.7%).
  2. H2 revenue H2 FY26 revenue ₹32.20 cr vs H1 FY26 ₹14.38 cr.
  3. Growth driver Asset-light model with WHO-GMP contract manufacturers redirects resources to sales and brand building.
  4. Margin risk Gross profit margin fell to 54.1% in FY26 from 63.2% in FY25.

Aptus Pharma Ltd results deck summary

Original filing on BSE

Aptus Pharma Ltd earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.